It was my pleasure to deliver welcome remarks to the ASCO-AIOM Clinical Research Course. What a bright group of young investigators gathered in Rome to further develop their clinical research skills.

Ready…set… The #ASCOAdvocacySummit Week of Action starts Monday! We’re calling on our members to advocate for improved access to #cancer care and robust research funding.

Sign up to participate virtually ➡️ brnw.ch/21wIJw1

Declining Medicare physician reimbursement threatens pt access to care. People with #cancer deserve better, so #ASCOAdvocacy appreciates Senate Finance Cmte/Senate Finance Committee working on this issue. Urge your lawmakers to act 👉asco.quorum.us/campaign/47094/

Thx, Energy and Commerce Committee for considering bills to make telehealth flexibilities permanent in Medicare. Beneficiaries w #cancer need care regardless of where they live. Urge lawmakers to cosponsor CONNECT for Health Act (S 2016/HR 4189). asco.quorum.us/campaign/55362/ #ASCOAdvocacy

We're a proud collaborator on the upcoming Joint Euro-American Forum on Cancer. Our Chief Medical Officer Julie Gralow & Lynn M. Schuchter, MD, FASCO will be participating in multiple sessions. See you in Dublin on April 24! 🇮🇪

Congratulations Chair Cole! #ASCOAdvocacy looks forward to working with you to increase funding for vital research at NIH & @TheNCI in FY25 and beyond.

Thank you AACR for the opportunity to co-moderate this #AACR24 -ASCO joint session w/ Dr. Greenberg on detection & treatment of MRD. Many thanks to our expert panelists for their dynamic & insightful presentations: Drs. Luis Diaz, Max Diehn, MD/PhD, Angie DeMichele, MD, MSCE, FASCO.

Looking forward to this! Please join us on May 6!

Insights into the latest ASCO NSCLC Living Guidelines available JCO Oncology Practice from Dr. Dwight Owen et al, addressing some common questions and providing helpful decision trees for personalizing systemic therapy for patients with NSCLC.

ascopubs.org/doi/10.1200/OP…

As we celebrate the one-year anniversary of the #NationalCancerPlan , we are committed to working with @TheNCI and all stakeholders to deliver optimal care to everyone and reduce the burden of cancer. #Every1HasaRole

Have you submitted your abstract? Ours are in! Join us @asco #ASCOBT24

Last day to submit your abstracts to #ASCOBT24 !!

Lots of research awards for the top40 ranked abstracts and also Merit awards for trainees!

Junior faculty and trainees opportunities are also being lined up 😊

ASCO ASCOPres Lillian Siu

Medical institutions in #LMICs in Central & Eastern Europe region are invited to participate in our education & knowledge-exchange program, the International Cancer Corps. The request for proposals is now open. Learn more ➡️ brnw.ch/21wIDQA #globonc

Strategies for Detecting Minimal Residual Disease and How to Apply It in the Clinic: AACR Immediate Past President Philip D. Greenberg and Lynn M. Schuchter, MD, FASCO Lynn M. Schuchter co-moderated this AACR-@ASCO Joint Session this evening at #AACR24 . Lynn Schuchter

Now available: Our new guideline clinical insights on therapy for stage IV #NSCLC with and without driver alterations ➡️ brnw.ch/21wICRm #LungCancer #lcsm

🎙️ Shaalan Beg MD MBA FASCO of Science 37 and Aparna Raj Parikh of Mass General Cancer Center discuss the promise of #ctDNA as a prognostic biomarker to improve risk stratification, detect recurrence, and inform adjuvant therapy in GI cancers on the #ASCODailyNews Podcast: brnw.ch/21wICIf #gicsm

We’re pleased to be at #AACR24 ! Visit our booth to learn about our latest resources for the oncology research community. Plus, access:

🤩 Attendee specials
🎁 New member gift
🌟 Giveaways

We look forward to seeing you!

Help reduce health disparities and improve lives of people living with cancer worldwide. Submit your solutions-oriented research to #ASCOQLTY24 by May 21. Accepted abstracts are published online as part of a JCO Oncology Practice supplement.

Learn more: brnw.ch/21wIzri

Join us for a virtual Grand Rounds on 5/6 to learn the latest from the #TAPUR Study, an ongoing clinical trial investigating targeted therapies for advanced cancer. Speakers include: Richard Schilsky Janet Freeman-Daily & Dr. Jens Rueter. Register: brnw.ch/21wICef #PrecisionMedicine

Monday afternoon at #AACR24 : The AACR and ASCO will host a joint session on minimal residual disease. Read a preview in AACR Annual Meeting News: bit.ly/3vTzyRz ASCOPres AACR President Philip D. Greenberg